Meet Dr. Rupesh KotechaRadiation Oncologist & Contributing Writer
Dr. Rupesh Kotecha is a renowned radiation oncologist at Miami Cancer Institute. His radiotherapy research has benefitted patients with mesothelioma, lung, breast, brain, esophageal and other cancers.
Last modified: December 20, 2022
- American Board of Radiology
- Lung Cancer
- Esophageal Cancer
- Radiation Therapy
About Dr. Kotecha
By utilizing the latest in radiation therapy technology, Dr. Rupesh Kotecha is paving the way for innovations in cancer treatment.
At the Miami Cancer Institute, Kotecha has integrated pencil-beam proton therapy into his practice, a safe alternative to traditional radiation. He has recently introduced Tumor Treating Fields to mesothelioma patients as a new noninvasive therapy option.
TTFields allows patients to apply adhesive pads to the skin that use alternating, low-voltage electric fields to disrupt cancer cell growth. Combined with chemotherapy, the treatment has improved outcomes for many mesothelioma patients. The Food and Drug Administration’s Humanitarian Device Exemption protocol allowed Kotecha to be one of the first in the U.S. to use TTFields for mesothelioma.
Kotecha earned his medical degree from Michigan State University College of Human Medicine in 2012. He later completed his residency in the radiation oncology program at Cleveland Clinic in 2017. Kotecha became board certified in radiation oncology by the American Board of Radiology in 2018.
At Miami Cancer Institute, Kotecha’s patient-first approach means people with mesothelioma are supported by a multidisciplinary team.
“I encourage patients to know all their options, especially with this rare disease,” Kotecha told The Mesothelioma Center at Asbestos.com.
Dr. Kotecha’s Role as Expert Contributor, Reviewer on Asbestos.com
Kotecha’s years of expertise in mesothelioma radiation therapy and radiosurgery research more than qualify him to be an expert contributor and reviewer for The Mesothelioma Center at Asbestos.com. Thanks to his contributions and reviews, medical information and content remain factually correct, current and consistent across Asbestos.com.